CVE-2026-19532: HAVELSAN Liman MYS · Path Traversal
Affects HAVELSAN Liman MYSSource CVE Database V5
Not known to be exploited · CVSS 5.3 Medium : upgrade to 2.3.4-1124 when convenient.
Data as of 7 Nov 2026, 23:24 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 18% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in 2.3.4-1124
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 24 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 8 Nov 2026.
What to do
Upgrade HAVELSAN Liman MYS to 2.3.4-1124.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| HAVELSAN Inc.Liman MYS | Affected
| Fixed in
|
AI-suggested
advisories for updates. If you cannot patch yet, restrict network access to the affected service and apply any recommended configuration mitigations from the vendor.
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: from 2.3.2 before 2.3.4-1124.